Utilising clinical parameters to improve the selection of nerve biopsy candidates
Internal Medicine Journal · 2023
DOI: 10.1111/imj.16099 ↗Kurz gefasst
Fachartikel in der Zeitschrift Internal Medicine Journal, 2023. Verfasst von Paul Kopanidis und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Northern Health, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Peripheral Nervous System Diseases, Vasculitis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
Background
Peripheral nerve biopsy is a valuable final diagnostic tool; however, histopathological results can be non‐diagnostic.
Aims
We aim to identify quality improvement measures by evaluating the pre‐biopsy assessment and diagnostic yield of specific histopathological diagnosis.
Methods
This was a retrospective study based on 10 years of experience with peripheral nerve biopsies at a single centre. Clinical data were obtained regarding pre‐biopsy history, examination, serum and cerebrospinal fluid (CSF) investigations, neurophysiology and peripheral nerve imaging. Based upon a histopathological outcome, patients were grouped into vasculitis, granulomatous and infiltrative (diagnostic) group, or a comparison group of non‐specific axonal neuropathy and normal (non‐specific/normal) group.
Results
From a cohort of 64 patients, 21 (32.8%) were included in the diagnostic group and 30 (46.9%) in the non‐specific/normal group. Clinical parameters associated with the diagnostic group were shorter history (mean 10.2 months vs 38.1), stepwise progression (81% vs 20%), neuropathic pain (85.7% vs 56.7%), vasculitic rash (23.8% vs 0%), mononeuritis multiplex (57.1% vs 10%), asymmetry (90.5% vs 60%), raised white cell count (47.6% vs 16.7%), myeloperoxidase antibody (19.1% vs 0%) and abnormal peripheral nerve imaging (33.3% vs 10%).
Conclusion
Selection of patients undergoing nerve biopsy requires careful consideration of clinical parameters, including peripheral nerve imaging. Several quality improvement measures are proposed to improve yield of clinically actionable information from nerve biopsy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Northern Health, Melbourne, Victoria, Australia.
- Department of Neurology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
- Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
- Neuropathology Department, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
ORCID-Profile: Paul Kopanidis
Zitieren
APA
Kopanidis, P., Baskozos, G., Byrne, E., Hofer, M., Themistocleous, A. C., Rinaldi, S., & Bennett, D. L. (2023). Utilising clinical parameters to improve the selection of nerve biopsy candidates. Internal Medicine Journal. https://doi.org/10.1111/imj.16099
Vancouver
Kopanidis P, Baskozos G, Byrne E, Hofer M, Themistocleous AC, Rinaldi S, et al. Utilising clinical parameters to improve the selection of nerve biopsy candidates. Internal Medicine Journal. 2023. doi:10.1111/imj.16099
BibTeX
@article{Kopanidis2023,
author = {Kopanidis, Paul and Baskozos, Georgios and Byrne, Elizabeth and Hofer, Monika and Themistocleous, Andreas C and Rinaldi, Simon and Bennett, David L},
title = {Utilising clinical parameters to improve the selection of nerve biopsy candidates},
journal = {Internal Medicine Journal},
year = {2023},
doi = {10.1111/imj.16099}
}
EUVIMED